Cell and Gene Therapy Manufacturing: An Emerging Frontier in Healthcare
The key drivers influencing the Cell and Gene Therapy Manufacturing Market expansion include its health benefits, including the treatment of blood cancers, lymphomas, leukemia, and solid tumors, and for the treatment of multiple myeloma.
Cell and gene therapy manufacturing services are a process of introducing cells or genes into the patients to treat a disease. The cells or genes can be sourced from the patient himself, or a donor. They are cultured during the production process, after which they are purified and packaged for delivery to the patient. The patient receives the cells or genes through injection or infusion.
Recommended by LinkedIn
In 2018, cancer was the second leading cause of death globally, accounting for over 9.6 million deaths, an average of one in six deaths. Cell and gene therapy treatment is widely used for treating various types of cancers which is escalating its demand consequently driving the cell and gene therapy manufacturing services.
A few of the recent developments in the cell and gene therapy manufacturing services market are:
Let,s Connect